Discover the latest: MASLD Oct. 2024 Publications
- Andrew M. Korda
- Oct 7, 2024
- 1 min read
Updated: Oct 9, 2024
Recent articles related to Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) published in October 2024:
1. MASLD and MASH at the crossroads of hepatology trials and cardiorenal metabolic trials
Journal: Journal of Internal Medicine
Abstract: This article discusses the significant public health challenges posed by steatotic liver disease and its interrelation with cardiovascular and renal health, emphasizing the need for integrated trials addressing MASLD and its comorbidities.
2. The MAFLD–MASLD debate: does cardiovascular risk prediction define the winner?
Journal: Liver International
Abstract: This editorial addresses the debate surrounding the reclassification of non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD) and its implications for cardiovascular risk prediction.
3. Comparative epidemiology of metabolic dysfunction-associated steatotic liver disease and non-alcoholic fatty liver disease
Journal: Journal of Gastroenterology and Hepatology
Abstract: This review analyzes the epidemiological differences between MASLD and non-alcoholic fatty liver disease (NAFLD), offering insights into diagnostic challenges and treatment strategies.
4. miR‐21p‐5p coordinates biological pathways to promote MASLD progression
Journal: Hepatology
Abstract: This study identifies the role of miR-21-5p in the progression of MASLD and suggests potential therapeutic targets for intervention.
5. Lifestyle interventions in the management of MASLD
Journal: Cell Metabolism
Abstract: This article discusses the impact of lifestyle modifications on managing MASLD and highlights the importance of a multidisciplinary approach in treatment.
Comentários